The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Streamlining urgent, same day oncology admissions from an ambulatory clinic and patient safety, patient experience, and team communication.
 
James Greytok
Employment - Alnylam; Dana-Farber Cancer Institute
Stock and Other Ownership Interests - Alynlam Pharmaceuticals
 
Lauren Sullivan
No Relationships to Disclose
 
Shauna Curran
No Relationships to Disclose
 
Jennifer Gilmore
No Relationships to Disclose
 
Julia K. Rotow
Honoraria - AstraZeneca
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bioatla; Bioatla; G1 Therapeutics; Genentech; Gritstone Bio; Guardant Health; Janssen; Jazz Pharmaceuticals; Lilly; Sanofi/Regeneron; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Anna Pullo
Employment - Brigham and Women's Hospital
 
Gail Marlowe
Employment - Dana-Farber Cancer Institute
 
Eric Yenulevich
No Relationships to Disclose
 
Nina Grenon
No Relationships to Disclose
 
Mary McCormack
No Relationships to Disclose
 
Hakim Lakhani
No Relationships to Disclose
 
Janet Bagley
Employment - Dana-Farber Cancer Institute
Travel, Accommodations, Expenses - Dana-Farber Cancer Institute
 
Andrew J. Wagner
Consulting or Advisory Role - AADi; BioAtla; Boehringer Ingelheim; Cogent Biosciences; Daiichi Sankyo; Deciphera; InhibRx; Lilly; Mundipharma; SERVIER
Research Funding - AADi (Inst); Cogent Biosciences (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst); Rain Therapeutics (Inst)
 
Martha Wadleigh
No Relationships to Disclose